These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31020919)

  • 21. CDC Grand Rounds: Public Health Strategies to Prevent Neonatal Abstinence Syndrome.
    Ko JY; Wolicki S; Barfield WD; Patrick SW; Broussard CS; Yonkers KA; Naimon R; Iskander J
    MMWR Morb Mortal Wkly Rep; 2017 Mar; 66(9):242-245. PubMed ID: 28278146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infant Mortality Associated With Prenatal Opioid Exposure.
    Leyenaar JK; Schaefer AP; Wasserman JR; Moen EL; O'Malley AJ; Goodman DC
    JAMA Pediatr; 2021 Jul; 175(7):706-714. PubMed ID: 33843963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical care of neonates undergoing opioid withdrawal in the immediate postpartum period.
    Oji-Mmuo CN; Jones AN; Wu EY; Speer RR; Palmer T
    Neurotoxicol Teratol; 2021; 86():106978. PubMed ID: 33838247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential problems and solutions of opioid-based treatment in neonatal opioid withdrawal syndrome (NOWS): a scoping review protocol.
    Mills-Huffnagle S; Nyland JE
    BMJ Open; 2023 Feb; 13(2):e067883. PubMed ID: 36806065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analgesia, Opioids, and Other Drug Use During Pregnancy and Neonatal Abstinence Syndrome.
    Jones HE; Kraft WK
    Clin Perinatol; 2019 Jun; 46(2):349-366. PubMed ID: 31010564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can umbilical cord testing add to maternal urine drug screen for evaluation of infants at risk of neonatal opioid withdrawal syndrome?
    Gersch H; Shah D; Chroust A; Bailey B
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2211706. PubMed ID: 37183045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between gestational age and the severity of neonatal abstinence syndrome.
    Gibson KS; Stark S; Kumar D; Bailit JL
    Addiction; 2017 Apr; 112(4):711-716. PubMed ID: 27886650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A retrospective, observational study on medication for opioid use disorder during pregnancy and risk for neonatal abstinence syndrome.
    Sujan A; Cleary E; Douglas E; Aujla R; Boyars L; Smith C; Guille C
    Fam Pract; 2022 Mar; 39(2):311-315. PubMed ID: 34537839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neonatal abstinence syndrome: Pharmacologic strategies for the mother and infant.
    Kraft WK; Stover MW; Davis JM
    Semin Perinatol; 2016 Apr; 40(3):203-12. PubMed ID: 26791055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neonatal Abstinence Syndrome: Prevention, Recognition, Treatment, and Follow-up.
    Schroeder M; White J
    S D Med; 2021 Dec; 74(12):576-583. PubMed ID: 35015949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neonatal Abstinence Syndrome: Review of Epidemiology, Care Models, and Current Understanding of Outcomes.
    MacMillan KDL
    Clin Perinatol; 2019 Dec; 46(4):817-832. PubMed ID: 31653310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Addressing the impact of opioids on women and children.
    Bianchi DW; Gillman MW
    Am J Obstet Gynecol; 2019 Aug; 221(2):123.e1-123.e4. PubMed ID: 31151658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maternal and iatrogenic neonatal opioid withdrawal syndrome: Differences and similarities in recognition, management, and consequences.
    Isaac L; van den Hoogen NJ; Habib S; Trang T
    J Neurosci Res; 2022 Jan; 100(1):373-395. PubMed ID: 33675100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Addressing opioid use disorder among rural pregnant and postpartum women: a study protocol.
    Bryan MA; Smid MC; Cheng M; Fortenberry KT; Kenney A; Muniyappa B; Pendergrass D; Gordon AJ; Cochran G
    Addict Sci Clin Pract; 2020 Oct; 15(1):33. PubMed ID: 33129355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida.
    Wang X; Zhu Y; Dave CV; Alrwisan AA; Voils SA; Winterstein AG
    Pharmacotherapy; 2017 Jul; 37(7):806-813. PubMed ID: 28500694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome reporting in neonates experiencing withdrawal following opioid exposure in pregnancy: a systematic review.
    Shan F; MacVicar S; Allegaert K; Offringa M; Jansson LM; Simpson S; Moulsdale W; Kelly LE
    Trials; 2020 Mar; 21(1):262. PubMed ID: 32164782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk Factors Associated with the Occurrence of Neonatal Opioid Withdrawal Syndrome: A Review.
    Kelty E; Preen DB
    CNS Drugs; 2019 Nov; 33(11):1113-1120. PubMed ID: 31686408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severity of neonatal opioid withdrawal syndrome with prenatal exposure to serotonin reuptake inhibitors.
    Bakhireva LN; Sparks A; Herman M; Hund L; Ashley M; Salisbury A
    Pediatr Res; 2022 Mar; 91(4):867-873. PubMed ID: 34588611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Influence of Mediators on the Relationship Between Antenatal Opioid Agonist Exposure and the Severity of Neonatal Opioid Withdrawal Syndrome.
    Devlin LA; Hu Z; Ounpraseuth S; Simon AE; Annett RD; Das A; Fuller JF; Higgins RD; Merhar SL; Smith PB; Crawford MM; Cottrell LE; Czynski AJ; Newman S; Paul DA; Sánchez PJ; Semmens EO; Smith MC; Whalen BL; Snowden JN; Young LW;
    Matern Child Health J; 2023 Jun; 27(6):1030-1042. PubMed ID: 36905529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-pharmacological care for opioid withdrawal in newborns.
    Pahl A; Young L; Buus-Frank ME; Marcellus L; Soll R
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013217. PubMed ID: 33348423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.